SCHEMBL6537853

SCHEMBL6537853

CCOC(=O)c1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1-n1ccnc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.43
MAPK1 P28482 3/20 0.42
USP2 O75604 2/20 0.42
TP53 P04637 2/20 0.42
RECQL P46063 1/20 0.42
HSD17B10 Q99714 1/20 0.42
LMNA P02545 4/20 0.41
HTT P42858 3/20 0.41
ALDH1A1 P00352 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
PKM P14618 1/20 0.41
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537740 0.86 CYP3A4 (0.46) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL6538171 0.86 CYP3A4 (0.50) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL6537902 0.86 CYP3A4 (0.46) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL8474859 0.85 CYP3A4 (0.52) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL6537466 0.85 TBXAS1 (0.42) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL6537513 0.83 CYP3A4 (0.46) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL6538031 0.83 CYP3A4 (0.44) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL6537955 0.83 CYP3A4 (0.46) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL6537966 0.82 CYP3A4 (0.45) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL6537629 0.82 MAPT (0.50) TP53HTTALDH1A1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed